Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Vassilios A. Sevastianos, Theodoros A. Voulgaris & Spyros P. Dourakis. (2020) Hepatitis C, systemic inflammation and oxidative stress: correlations with metabolic diseases. Expert Review of Gastroenterology & Hepatology 14:1, pages 27-37.
Read now
Read now
Articles from other publishers (19)
Daniela S. Allende & Lisa M. Yerian. 2024. Gastrointestinal and Liver Pathology. Gastrointestinal and Liver Pathology
489
556
.
Xiaoxia Wang, Yu Cao, Jia Guo, Dezhao Li, Haitao Zhang, Qingkun Song & Jun Lu. (2023) Association between MTTP genotype (-493G/T) polymorphism and hepatic steatosis in hepatitis C: a systematic review and meta-analysis. Lipids in Health and Disease 22:1.
Crossref
Crossref
Thamiris Vaz Gago Prata, Caroline Manchiero, Bianca Peixoto Dantas, Arielle Karen da Silva Nunes, Fátima Mitiko Tengan & Mariana Cavalheiro Magri. (2022) Effect of MTTP -493G/T, I128T, Q95H and Q244E polymorphisms on hepatic steatosis in patients with chronic hepatitis. Clinics 77, pages 100094.
Crossref
Crossref
Mohamed Shengir, Mohamed Elgara & Giada Sebastiani. (2021) Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond. World Journal of Gastroenterology 27:17, pages 1959-1972.
Crossref
Crossref
Riccardo NEVOLA, Carlo ACIERNO, Pia C. PAFUNDI & Luigi E. ADINOLFI. (2021) Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management. Minerva Medica 112:2.
Crossref
Crossref
P. O. BogomolovA. O. BueverovE. A. FedosinaV. E. BakirovaS. V. Koblov. (2020) Clinical parallels and experience of antivira l therapy in chronic hepatitis with polycystic ovary syndrome. Experimental and Clinical Gastroenterology 174:2, pages 71-79.
Crossref
Crossref
Mariana Cavalheiro Magri, Thamiris Vaz Gago Prata, Caroline Manchiero, Bianca Peixoto Dantas, Celso Carmo Mazza & Fátima Mitiko Tengan. (2017) Genetic variation in the microsomal triglyceride transfer protein (−493G/T) is associated with hepatic steatosis in patients infected with hepatitis C virus. BMC Infectious Diseases 17:1.
Crossref
Crossref
Yan Li, Yongcheng Dong, Ziyan Huang, Qifan Kuang, Yiming Wu, Yizhou Li & Menglong Li. (2017) Computational identifying and characterizing circular RNAs and their associated genes in hepatocellular carcinoma. PLOS ONE 12:3, pages e0174436.
Crossref
Crossref
Maha Akl, Ali EL Hindawi, Maha Mosaad, Ahmed Montasser, Ahmed El Ray, Heba Khalil, Amgad Anas, Raffat Atta, Valerie Paradis, Ahmed Abdel Hadi & Olfat Hammam. (2016) Fibrosis in Chronic Hepatitis C: Correlation between Immunohistochemically-Assessed Virus Load with Steatosis and Cellular Iron Content. Open Access Macedonian Journal of Medical Sciences 4:4, pages 578-584.
Crossref
Crossref
Ester Vanni, Elisabetta Bugianesi & Giorgio Saracco. (2016) Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?. Digestive and Liver Disease 48:2, pages 105-111.
Crossref
Crossref
Theodoros Voulgaris & Vassilios A. Sevastianos. (2016) Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus. Hepatitis Research and Treatment 2016, pages 1-8.
Crossref
Crossref
Shira Yair-Sabag, Elchanan Nussinson, Ofir Ben-Assuli, Fahmi Shibli, Azmi Shahbari & Shira Zelber-Sagi. (2016) Retrospective study of the associations between hepatitis C virus infection and metabolic factors. World Journal of Hepatology 8:30, pages 1269.
Crossref
Crossref
Nabiha Faisal, Khalid Mumtaz, Max Marquez, Eberhard L. Renner & Leslie B. Lilly. (2014) High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation. Hepatology International 9:1, pages 76-83.
Crossref
Crossref
Julien Vergniol, Jérôme Boursier, Clélia Coutzac, Sandrine Bertrais, Juliette Foucher, Camille Angel, Faiza Chermak, Isabelle Fouchard Hubert, Wassil Merrouche, Frédéric Oberti, Victor de Lédinghen & Paul Calès. (2014) Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C. Hepatology 60:1, pages 65-76.
Crossref
Crossref
Pavel Strnad, Renwar Nuraldeen, Janett Fischer, Thomas Berg & Christian Trautwein. (2014) Hepcidin as a predictor of treatment response in chronic hepatitis C infection. Hepatology 59:4, pages 1648-1648.
Crossref
Crossref
Thomas Karlas, David Petroff, Nikita Garnov, Stephan Böhm, Hannelore Tenckhoff, Christian Wittekind, Manfred Wiese, Ingolf Schiefke, Nicolas Linder, Alexander Schaudinn, Harald Busse, Thomas Kahn, Joachim Mössner, Thomas Berg, Michael Tröltzsch, Volker Keim & Johannes Wiegand. (2014) Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy. PLoS ONE 9:3, pages e91987.
Crossref
Crossref
Rosa Zampino. (2014) Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. World Journal of Hepatology 6:9, pages 677.
Crossref
Crossref
Ludovico Abenavoli. (2014) Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3. World Journal of Gastroenterology 20:41, pages 15233.
Crossref
Crossref
P. Loria, G. Marchesini, F. Nascimbeni, S. Ballestri, M. Maurantonio, F. Carubbi, V. Ratziu & A. Lonardo. (2014) Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. Atherosclerosis 232:1, pages 99-109.
Crossref
Crossref